Cervical cancer
Phase III randomized trial of Cisplatin plus Paclitaxel with and without Bevacizumab versus the doublet without platinum, Topotecan plus Paclitaxel, with and without Bevacizumab, in recurrent or persistent stage IVB cervical carcinoma.
Phase II exploratory study to evaluate the efficacy and safety of weekly topotecan in the treatment of persistent or relapsing cervical cancer after failure of first-line treatment with platinum derivatives.